Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications
- PMID: 18538135
- DOI: 10.1016/j.cca.2008.05.010
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications
Abstract
Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage. Serum alpha-fetoprotein (AFP) is one of the most common diagnostic markers for hepatocellular carcinoma. However, its diagnostic value is more and more questioned. Therefore, research has focussed on AFP related parameters (AFP mRNA and AFP glycoforms). The aim of this paper is to review the present knowledge on AFP and its related parameters in diagnosing and monitoring HCC. AFP related parameters can be arranged in two types: AFP mRNA and AFP glycoforms. AFP mRNA is a potentially prognostic marker and AFP mRNA assays are based on PCR techniques. The AFP glycoforms have diagnostic potential and assays are based on isoelectric focussing and lectin affinity electrophoretic methods. Up to now the diagnostic use of the AFP related parameters is limited. Although some of them are recommended as a complementary test, they cannot (yet) replace serum AFP as the golden standard of diagnostic markers for hepatocellular carcinoma.
Similar articles
-
Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):538-44. Hepatobiliary Pancreat Dis Int. 2006. PMID: 17085339
-
Structures of disease-specific serum alpha-fetoprotein isoforms.Br J Cancer. 2000 Nov;83(10):1330-7. doi: 10.1054/bjoc.2000.1441. Br J Cancer. 2000. PMID: 11044358 Free PMC article.
-
Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.Hepatogastroenterology. 2008 Nov-Dec;55(88):2200-6. Hepatogastroenterology. 2008. PMID: 19260505
-
Specific molecular markers in hepatocellular carcinoma.Hepatobiliary Pancreat Dis Int. 2007 Jun;6(3):241-7. Hepatobiliary Pancreat Dis Int. 2007. PMID: 17548245 Review.
-
[Alpha-fetoprotein: diagnostic value in hepatic disorders].Pol Merkur Lekarski. 2000 Jun;8(48):420-3. Pol Merkur Lekarski. 2000. PMID: 10967924 Review. Polish.
Cited by
-
An overview of biomarkers for the diagnosis of hepatocellular carcinoma.Hepat Mon. 2012 Oct;12(10 HCC):e6122. doi: 10.5812/hepatmon.6122. Epub 2012 Oct 20. Hepat Mon. 2012. PMID: 23162601 Free PMC article.
-
Tumor markers for hepatocellular carcinoma.Mol Clin Oncol. 2013 Jul;1(4):593-598. doi: 10.3892/mco.2013.119. Epub 2013 May 13. Mol Clin Oncol. 2013. PMID: 24649215 Free PMC article. Review.
-
A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.PLoS One. 2014 Sep 19;9(9):e107986. doi: 10.1371/journal.pone.0107986. eCollection 2014. PLoS One. 2014. PMID: 25238238 Free PMC article.
-
Present and future possibilities for early diagnosis of hepatocellular carcinoma.World J Gastroenterol. 2010 Jan 28;16(4):418-24. doi: 10.3748/wjg.v16.i4.418. World J Gastroenterol. 2010. PMID: 20101765 Free PMC article. Review.
-
Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.Cell Immunol. 2019 Jan;335:59-67. doi: 10.1016/j.cellimm.2018.10.011. Epub 2018 Nov 1. Cell Immunol. 2019. PMID: 30392891 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
